April 2009 Declared National Safe Handling Awareness Month

April 2009 Declared National Safe Handling Awareness Month

In an act to further education surrounding the safe handling of hazardous drugs in the healthcare setting, April 2009 has been declared the first-ever National Safe Handling Awareness Month with Monday, April 20, 2009 being declared the first-ever National Safe Handling Awareness Day.

Columbus, OH (PRWEB) February 24, 2009 -- In an act to further education surrounding the safe handling of hazardous drugs in the healthcare setting, April 2009 has been declared the first-ever National Safe Handling Awareness Month with Monday, April 20, 2009 being declared the first-ever National Safe Handling Awareness Day.

The proclamation of National Safe Handling Awareness Month follows the need for increased safe handling cognizance given the known risks associated with exposure to hazardous drugs (such as chemotherapy agents). According to an alert published by the National Institute for Occupational Safety and Health (NIOSH), "working with or near hazardous drugs in healthcare settings may cause skin rashes, infertility, miscarriage, birth defects and possibly leukemia or other cancers." Further evidence to support the need to take action in this area may be found below.

In recognition of National Safe Handling Awareness Month, a variety of regional and national continuing education (CE) activities will be scheduled throughout April. The headline event, a complimentary, nationwide CE webcast, will take place on April 20th from 1:00-2:00pm EST. The event will be followed by a live "Ask the Experts" session featuring today's industry thought leaders:

Keynote speakers:

Byron Peters, RPh

Director of Pharmacy

Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO

MiKaela Olsen, RN, MS, OCN

Oncology and Hematology Clinical Nurse Specialist

Johns Hopkins Hospital, Baltimore, MD

Guest Speaker:

James Jorgenson, RPh, MS, FASHP

Executive Director, Pharmacy Services

Clarian Health Partners, Methodist Hospital, Indianapolis, IN

This initiative is supported by an unrestricted educational grant provided by Carmel Pharma, Inc. - the official sponsor of National Safe Handling Awareness Month and the maker of PhaSeal®, the only clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs.

Participants may visit www.statce.com/safehandling for more information or to register for the program.

The Importance of Safe Handling

* The World Health Organization predicts a 50 percent increase of cancer cases over the next 20 years; this, combined with more potent chemotherapy drugs - as well as an increase in the use of hazardous drugs to treat non-malignant illnesses - will continue to elevate risk of exposure.

* Two separate studies investigating the toxicity in healthcare personnel who handle cytotoxic (hazardous) drugs revealed a 40-50 percent increased risk for miscarriage. A total of 7094 pregnancies of 2976 pharmacy and nursing staff were examined.

* A national survey conducted by the Environmental Working Group, the American Nurses Association, Health Care Without Harm and the Environmental Health Education Center at the University of Maryland School of Nursing showed that there are links between nurses' occupational exposure to hazardous drugs and the health problems they develop such as cancer, asthma, miscarriages and children's birth defects.

About Safe Handling Awareness Month

April has been designated the first-ever National Safe Handling Awareness Month in an effort to raise awareness of the occupational risks associated with handling hazardous drugs and educate healthcare providers on the U.S. guidelines and safety measures that may be taken to prevent hazardous drug exposure. As the highlight of National Safe Handling Awareness Month, National Safe Handling Awareness Day will bring together national and regional educational opportunities collectively aimed at preserving the health and wellbeing of the oncology healthcare professionals who devote their lives to helping others. National Safe Handling Awareness Month and National Safe Handling Awareness Day are officially sponsored by Carmel Pharma, the maker of the PhaSeal® System - today's only clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. For additional details on National Safe Handling Awareness Month/Day, visit www.carmelpharmausa.com/aware5 or call 866-487-9250.

About Carmel Pharma (the maker of the PhaSeal® System)

The PhaSeal System is manufactured by Carmel Pharma ab in Gothenburg, Sweden and is distributed from its U.S. affiliate office, Carmel Pharma, Inc., in Columbus, OH. PhaSeal has been in use in the United States since 2000 and implemented in more than 1000 cancer facilities, infusion centers and private practices, including M.D. Anderson and Texas Children's in Houston, TX; City of Hope in Duarte, CA; Dana Farber Cancer Institute in Boston, MA; SwedishAmerican Hospital in Rockford, IL; and Johns Hopkins University in Baltimore, MD, just to name a few. For more information on Carmel Pharma or the PhaSeal System, please visit www.phaseal.com. To request additional product details, high-resolution imagery, story ideas and expert references, or to learn more about the topic of safe handling from today's clinical thought leaders, please contact Emily Frydendal at 614-318-2635.

# # #

Contact Information Laura Gonzalez

STAT CE

http://www.statce.com/safehandling

888-247-8700

UCSF Gallo Study Finds Hormone Disorder Drug Could Help Drinkers Stay Sober

UCSF Gallo Study Finds Hormone Disorder Drug Could Help Drinkers Stay Sober

A drug prescribed for male and female infertility and menstrual disorders could hold the key to a more effective treatment for alcoholism, according to a study by researchers at the UCSF-affiliated Ernest Gallo Clinic and Research Center (www.galloresearch.org).

(Vocus) February 24, 2009 -- A drug prescribed for male and female infertility and menstrual disorders could hold the key to a more effective treatment for alcoholism, according to a study by researchers at the UCSF-affiliated Ernest Gallo Clinic and Research Center (www.galloresearch.org).

The study showed that "alcoholic" rodents, when injected with the drug cabergoline, decreased their alcohol consumption and alcohol-seeking behavior and were less likely to relapse.

Cabergoline, which is marketed under the trade name Dostinex, is approved by the Food and Drug Administration in pill form to treat conditions caused by excess of the hormone prolactin.

The study, led by Dorit Ron, PhD, a principal investigator at the Gallo Center and associate professor of neurology at UCSF, is now on line (February 20, 2009), in the journal "Biological Psychiatry." (See end of news release for link to paper.)

Notably, cabergoline did not impact the rats' consumption of sucrose and, in a subgroup of binge-drinking mice, the drug did not appear to significantly affect intake of water or saccharin.

"This is encouraging," says Ron, "because it demonstrates that cabergoline is specific for alcohol, but does not affect general reward or pleasure. One of the problems with some existing drugs to treat alcoholism is a side effect that decreases pleasure, making compliance an obstacle to sobriety."

The research builds on an earlier, provocative finding by Ron and her colleagues regarding the protein GDNF (glial cell line-derived neurotrophic factor), which they had injected into rats' VTA (ventral tegmental area) brain region, associated with drug-seeking behavior.

In this earlier study, the scientists had trained rats to consume alcohol. Some, like humans, drank in moderation, while others binged. But when GDNF was administered, both heavy and light drinkers lost at least some of their craving for alcohol. This effect became apparent within 10 minutes and lasted at least 24 hours, the scientists discovered. Importantly, administration of GDNF into the brain prevented the rats from relapsing after a period of abstinence.

While the discovery broke new ground, the scientists knew that GDNF could not be used to treat alcoholic humans because its molecule is too large to cross the blood-brain barrier. So, in the present study, Ron and her colleagues looked at cabergoline, a compound that has been shown in cells to increase the expression of GDNF.

After establishing that cabergoline treatment resulted in an increase of the level of GDNF and activation of the GDNF pathway in the rats' VTA, the researchers sought to test its impact on rodents' drinking habits.

Rats underwent a two-month training program in which they learned to press a lever to obtain alcohol. Researchers found that when rats were injected with cabergoline, they were less likely to press the lever. The higher the dose of cabergoline, the lower the number of lever presses reported. The researchers also found that binge-drinking mice consumed less alcohol after cabergoline administration.

In further study, the researchers found that cabergoline was effective in reducing both craving for alcohol and relapse to drinking. Relapse is a critical issue for alcoholic patients trying to stay abstinent.

As further evidence of the interplay between cabergoline and GDNF, alcohol intake was tested on mice that had been genetically engineered to have a single copy of the GDNF gene, and therefore less GDNF in the brain. As expected, the scientists found that the drinking habits of these genetically modified mice were not affected by cabergoline.

Although the results of the study offer fresh hope to problem drinkers, Ron cautions that human clinical trials are needed before cabergoline can be safely prescribed. Higher doses of cabergoline have been used to treat Parkinson's disease and have been linked to heart valve problems.

"However," notes Ron, "we show that in mice and rats, a low dose of the drug is enough to reduce excessive alcohol consumption, alcohol seeking and relapse. The dose is similar to what is given to humans for the treatment of hyperprolactinemia."

Cabergoline may eventually be prescribed for other addictions. A pilot study conducted on cocaine addicts, cited in Ron's paper, reported a substantial reduction in cocaine use.

In the United States, 17.6 million people -- approximately one in every 12 adults -- abuses alcohol or is alcohol-dependent, according to the National Institutes of Health. But there are just three medications approved to treat alcohol dependence -- disulfiram (Antabuse), naltrexone (Depade, ReVia), and acamprosate (Campral).

Lead author of the study is Sebastien Carnicella, PhD, postdoctoral fellow at the Gallo Center. Co-authors are Dao-Yao He, PhD, senior research scientist; Patricia Janak, PhD, associate professor of neurology at UCSF; Selena Bartlett, PhD, director of the center's preclinical development group; Carsten Nielsen, PhD, associate research scientist; and Somayeh Ahmadiantehrani, graduate student.

Research was funded by the National Institutes of Health and the State of California for medical research on alcohol and substance abuse through UCSF.

The Ernest Gallo Clinic and Research Center at UCSF is one of the world's preeminent academic centers for the study of the biological basis of alcohol and substance use disorders. It is the only center studying alcoholism in the United States that is based in a department of neurology. Gallo Center discoveries of potential molecular targets for the development of therapeutic medications are extended through preclinical and proof-of-concept clinical studies.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions and excellence in patient care.

Link to paper: http://tinyurl.com/dh6dnk

###

Contact Information Jennifer O’Brien

http://www.ucsf.edu

415-476-2557

Paving the Way for Peace in the Middle East with Mind-Body Skills

Paving the Way for Peace in the Middle East with Mind-Body Skills

Truce talks are gridlocked, but this mission to provide trauma relief to both sides of the conflict goes forward. Dr. James S. Gordon and his international team plans a training of health and mental health professionals in both Israel and Gaza--the only program of its kind working in both Israel and Gaza. After arriving February 28th, 2009. With The Center for Mind-Body Medicine's groundbreaking model which teaches self-care techniques (such as meditation, guided imagery, biofeedback, and yoga, as well as self-expression in words, drawing, and movement, all in a supportive small group), Dr. Gordon and his team will help heal the wounds of war and bring relief to those suffering following the devastating siege on Gaza.

Washington, D.C., Tel Aviv, and Gaza (PRWEB) February 23, 2009 -- As truce talks drag on between Israel and Gaza, James S. Gordon, M.D., the distinguished psychiatrist who leads the Washington D.C.-based Center for Mind-Body Medicine (http://www.cmbm.org), will on March 4, 2009 lead an international team of Christian, Muslim, and Jewish mental health professionals into Gaza in a groundbreaking effort to relieve population-wide psychological trauma in that war-devastated Israeli-occupied territory. The team will arrive in Israel February 28, 2009 and make their way to a border crossing.

For the last seven years, Dr. Gordon and his CMBM team have been working intensively with the traumatized population in Gaza and Israel separately and jointly -- they are the only organization doing so. During this time, they've trained 300 Israeli professionals and 90 in Gaza to develop comprehensive, scientifically based programs that are effectively treating widespread post traumatic stress disorder, major depression, anxiety, violence, and despair.

CMBM's pioneering program, which recently received a research award from the US Department of Defense, combines such mind-body techniques as meditation, guided imagery, biofeedback, and yoga with self-expression in words, drawings, and movement in a supportive small group setting.

CMBM's program is a powerful force for peace for those living in Gaza. Before the recent Israeli invasion, CMBM's Gaza team, which has treated 15-20,000 children and adults, was providing up to 75 ten-week long mind-body groups every three months. In the aftermath of the devastation, the number of groups has tripled. The CMBM approach is currently also being offered to hundreds of families that lost members in the conflict, to orphaned children, mothers with 'failure to thrive' infants, and depressed, suicidal, and violent children and adults.

A wealth of data supports and informs CMBM's unique, highly effective model, which has been used to help traumatized populations in postwar Kosovo, post-Katrina New Orleans, as well as Israel and Gaza, and is now being implemented on an increasingly large scale with US military returning from Iraq and Afghanistan and their families.

As Dr. Gordon says, "The CMBM model is welcomed by people of all ages and races around the world because it is educational, non-stigmatizing, and demonstrably beneficial. It can be easily taught and can be used by all people of all ages on their own." Dr. Gordon describes this groundbreaking approach in his newest book Unstuck: Your Guide to the Seven-Stage Journey Out of Depression (Penguin Press; June 2008).

The results of CMBM's program are astonishing. A randomized controlled trial (RCT) on the use of the model with war-traumatized children in Kosovo -- the first RCT of any intervention with war-traumatized children -- was published in the prestigious Journal of Clinical Psychiatry in 2008; it showed an 80% decrease in symptoms following 12 sessions of mind-body skills groups. Also, data collected on the first 500 children and 600 adults in the CMBM Gaza program revealed significant decreases in symptoms of PTSD and depression and anger and increased hopefulness in those who participated in CMBM groups, gains which were largely maintained even during the ongoing siege of Gaza at six months' follow-up.

After four days working with the CMBM faculty in Israel and visiting with people affected by the Palestinian shelling in Sderot and Ashkelon, Dr. Gordon and his team will enter Gaza. During the first several days, they will visit with some of the thousands who have sought out CMBM-trained counselors to help them deal with the loss of family members and friends. During the following five days, Dr. Gordon and his colleagues will supervise the 15-member CMBM Gaza leadership team as they prepare 150 more of the most committed mental health professionals, including school psychologists and school counselors, to offer CMBM's program to Gaza's devastated children and their families.

Journalists are invited to accompany Dr. Gordon as he meets with CMBM's Israeli staff prior to entering Gaza and visits Sderot, and as the team interviews individuals and families throughout Gaza. There will be opportunities for interviews with Dr. Gordon and his Palestinian leadership team, traumatized families who have been aided, as well as the possibility to observe the training program. A short article on Dr. Gordon's work in Gaza (http://www.nytimes.com/2009/01/13/health/views/13case.html?ref=health) which appeared in the New York Times.

Dr. Gordon is a dynamic public speaker with a wealth of personal stories of children and adults he has helped find healing in the midst of loss and despair. A respected and world-renowned expert in mind-body medicine, he can bring the human aspects of this story to life in any medium -- radio, television, or print -- with a warm, knowledgeable voice and his wealth of experience. He is available for immediate comment and interview.

###

Contact Information Dr. Gordon EA

The Center for Mind-Body Medicine

http://www.cmbm.org

202-537-6837

Ugandan Children Receive Life-Saving Treatment For Heart Defects At Children's National Medical Center

Ugandan Children Receive Life-Saving Treatment For Heart Defects At Children's National Medical Center

Through partnership with Samaritan's Purse and Gift of Life, patients travel to United States **Media Note: Patients will be at Children's National for farewell visit on Tuesday, February 24**

Washington, DC --On February 12, two Ugandan children received life-saving procedures at Children's National Medical Center (http://www.childrensnational.org/?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda) to correct severe heart defects. Without cardiac surgery, the young boys would likely have died before adulthood, but they now have a normal life expectancy.

As part of the Phase I of a global initiative to bring attention to the health needs of Ugandan children, 15-month-old Daniel Kamaramasu and 2 ½-year-old Allan Wassanyi traveled 5,000 miles to receive treatment unavailable at home. Daniel, who was born with a blocked valve between his heart and lungs, was successfully treated using a cardiac catheterization balloon procedure by Michael Slack, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocId=470&Name=Michael%20Slack?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda). Allan, who had a very large hole in his heart, underwent successful open heart surgery by Richard Jonas, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocID=1195&Name=Richard%20Jonas?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda).

The boys came to Children's National through a partnership with international relief organization Samaritan's Purse, Gift of Life International (GOLI), and other organizations. Through this partnership, pediatric cardiologist Craig Sable, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocId=424&Name=Craig%20Sable?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda) has led seven medical missions to Uganda in an effort to provide treatment for patients and ultimately build a sustainable cardiac surgery program in Uganda. More than 100 children have received life-saving treatment since the program began in 2003.

"With the dedication of organizations like Samaritan's Purse and Gift of Life, patients from around the world have access to the expert pediatric care that is available to children in the United States," said Dr. Sable.

Added Cindy Bonsall, director of Samaritan's Purse's Children's Heart Project: "We're glad this partnership has enabled so many Ugandan children to receive the cardiac care they deserve. We're glad they will be returning home soon with a second chance at life."

A key component of the missions to Uganda has been training Ugandan surgeons. Through training provided by Dr. Sable and colleagues, Ugandan surgeons are now on the verge of doing simple cardiac procedures on their own. Dr. Sable directs the Telemedicine Program at Children's National, which provides training and educational opportunities around the world.

The groups have joined forces to implement "Our Hearts Are In Uganda," which will focus all of GOLI's efforts in Uganda. The first phase of the program included treatment for Daniel, Allan, and three other children at hospitals in the United States. The next phase will bring 25 more Ugandan children to hospitals throughout the world to receive life-saving treatment for heart defects.

"We have saved the lives of more than 10,000 children, and through this partnership, we hope to expand our reach, to ultimately create a program in Uganda to ensure that all the children have access to the medical care they need," said Lou del Rosario, vice chairman of GOL District 7230, who was instrumental in raising funds for Allan's operation.

MEDIA NOTE: The patients will be returning to Children's National for a farewell visit on Tuesday, February 24. The patients and Dr. Craig Sable will be available for interviews. Contact Emily Dammeyer or Jenn Leischer at 202-476-4500.

About Children's National Medical Center (http://www.childrensnational.org/about/?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda)

Children's National Medical Center, located in Washington, DC, is a proven leader in the development of innovative new treatments for childhood illness and injury. Children's has been serving the nation's children for more than 135 years. Children's National is proudly ranked among the best pediatric hospitals in America by US News & World Report and the Leapfrog Group. For more information, visit www.childrensnational.org.

About Samaritan's Purse

Samaritan's Purse identifies children needing life-saving heart treatment through its' Children's Heart Project. The international relief organization identifies children overseas who need heart surgery, matches them with hospitals and specialists willing to donate their time and services, places them with a local host family, and arranges international travel and an interpreter. More than 550 children from nine countries have been brought to North America for medical and surgical care not available in their home countries.

About Gift of Life International

Gift of Life is a Rotary based program in more than 50 Rotary Clubs and Districts on 6 continents. GOLI aims to save as many children's lives as possible by providing life saving open heart surgery to children from infancy to 18 years of age with congenital heart defects. GOLI has been responsible for saving more than 10,000 lives during the past 33 years.

###

Contact Information Emily Dammeyer

Children's National Medical Center

http://www.childrensnational.org

202-476-4500

Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List

Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List

Reprints Desk, Inc., the content workflow company, today announced that the company has been named as one of "KMWorld's 100 Companies that Matter in Knowledge Management" by KMWorld Magazine.

Los Angeles, Calif. (PRWEB) February 23, 2009 -- Reprints Desk, Inc., the content workflow company (http://www.reprintsdesk.com/main/home.aspx), today announced that the company has been named as one of "KMWorld's 100 Companies that Matter in Knowledge Management" by KMWorld Magazine.

KMWorld's annual list, now in its eighth year, is compiled by knowledge management (KM) practitioners, theorists, analysts, vendors, and customers. Companies that have previously been named to the list include Google, Apple, Oracle, SAP, and EMC.

"Each company embodies as part of its culture agile and limber execution of its mission, embracing a spirit of both adaptability and innovation," said Hugh McKellar, KMWorld editor in chief.

In 2008, Reprints Desk achieved a number of accomplishments:

• Ranked first overall and in each category within the Document Delivery (http://www.reprintsdesk.com/main/docdel_overview.aspx) Best Practices and Vendor Scorecard Report published by Outsell, Inc.

• Served more than 50% of the world's top-50 pharmaceutical companies

• Launched eCTD Article Service (http://www.reprintsdesk.com/main/news.aspx) for regulatory submissions

• Established an office in Germany to support European sales

• Became a document supplier on FIZ Karlsruhe's full-text broker service FIZ AutoDoc

• Signed an agreement with the Copyright Clearance Center to integrate rights management from Rightsphere into the document delivery workflow

Reprints Desk is headquartered in Los Angeles, California, and was founded in 2006 by document delivery pioneer Peter Derycz. The company provides software services that simplify how healthcare companies and other research-oriented enterprises procure, manage, and share peerreviewed journal articles and other copyright-protected content.

About KMWorld

The leading information provider serving the Knowledge, Document and Content Management systems market, KMWorld informs more than 50,000 subscribers about the components and processes - and subsequent success stories - that together offer solutions for improving business performance. KMWorld is a publishing unit of Information Today, Inc.

About Reprints Desk ®

Reprints Desk, Inc. (www.reprintsdesk.com), is a content technology and services company that simplifies how healthcare companies and other enterprises procure, manage and share scientific journal articles and other copyright-protected content. The company's workflow solutions and end user tools help customers effectively use peer-reviewed literature in product promotions, regulatory submissions, and research. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk currently serves more than half of the world's Top-50 pharmaceutical companies and earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc. Reprints Desk is a Derycz Scientific, Inc. (OTC: DYSC.PK) company. For more information about Reprints Desk, contact Ian Palmer at +1 (707) 658-1931.

Public and Media Relations Contacts:

Ian Palmer, Head of Marketing

Reprints Desk, Inc. | +1 707.658.1931

ipalmer @ reprintsdesk.com

# # #

Contact Information Ian Palmer

Reprints Desk

http://www.reprintsdesk.com

707.658.1931

Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement

Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement

Dalton Pharma Services announces the renewal of its Chemistry Services Agreement with Boehringer Ingelheim (Canada) Ltd. Under the agreement Dalton will continue to provide chemistry services in support of Boehringer's pharmaceutical development programs.

Toronto, Ontario, Canada (PRWEB) February 23, 2009 -- Dalton Pharma Services announces the renewal of its Chemistry Services Agreement with Boehringer Ingelheim (Canada) Ltd. Under the agreement Dalton will continue to provide chemistry services in support of Boehringer's pharmaceutical development programs.

Peter Pekos, President of Dalton Pharma Services, said: "We are extremely pleased to continue our relationship with Boehringer Ingelheim (Canada) Ltd. The renewal of our chemistry services agreement demonstrates Boehringer Ingelheim's deep commitment to research in Canada. We look forward to another successful collaboration with this world class organization."

About Dalton Pharma Services:

Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer (http://www.dalton.com/) that supplies chemistry, medicinal chemistry and analytical services (http://www.dalton.com/contract_analytical.htm) to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry, fine chemical manufacture, custom peptides and antisense oligo production. Dalton provides cGMP manufacturing (http://www.dalton.com/facilities.htm) and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton can produce active pharmaceutical ingredients (API), at the gram or kilogram scale. Dalton can carry out sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton's analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients.

Contact:

Peter Pekos

Dalton Pharma Services

416-661-2102

ppekos (at) dalton (dot) com

###

Contact Information Peter Pekos

Dalton Pharma Services

http://www.dalton.com/

416-661-2102

Separating Fact from Bioidentical Hype

Separating Fact from Bioidentical Hype

Hot from Menopausal Symptoms and Bothered by the Media Hype about Hormone Replacement? People are hearing about bioidentical hormone replacement along with more traditional types of prescribed hormone medication from the Oprah show and other media. Lets separate Fact from Fiction. The word "bioidentical" is not an accurate medical description of this new, unregulated substance and it certainly is not exactly like the hormones the body produces otherwise there would not be a measurable and clinically evident toxic build-up in the body. In "Revitalize Your Hormones: Dr. Dale's 7 Steps to a Happier, Healthier, and Sexier You" (Wiley; May 2005), Dr. Theresa Dale offers a medically proven natural alternative to invasive and dangerous hormone replacement therapies. Dale invented the world's only clinically proven, FDA registered, homeopathic hormone rejuvenation formulas used for restoring hormone balance without side effects.

(PRWEB) February 19, 2009 -- Hot from Menopausal Symptoms and Bothered by the Media Hype about Hormone Replacement? People are hearing about bioidentical hormone replacement along with more traditional types of prescribed hormone medication from the Oprah show and other media. Lets separate Fact from Fiction. The new buzz word "bioidentical" is deceptive. It's not an accurate medical description of this new, unregulated substance and it is not exactly like the body produces. Clearly there is a measurable and clinically evident toxic build-up in the body.

Bioidentical hormone replacement is not natural even though it originates from yam or soy; it has been compounded and thus a synthetic. That's right; health providers perform thousands of before and after saliva tests on patients and it is clear that there is a toxic build up of all hormone replacement including bioidentical HRT.

Women are wary of recent warnings linking hormone replacement therapy with an increased risk for heart disease, stroke and breast cancer, more and more women are turning to alternative and natural ways to balance their hormone levels. Studies have shown that using hormones such as Prempro, Othro-Prefest or Premphase and bioidentical HRT causes the body to shut down production of its own hormones creating a dependency. Hormone replacement therapy can also elevate existing hormone levels to toxically high amounts, which can tax the adrenal glands, burden the liver, kidneys, and circulatory and immune systems.

Yet, there is a superior way to get both clinically proven and evidence based relief without being exposed to the toxic effects of ALL of these drugs. Health providers throughout the US are using FDA registered NuFem & EndoPure Homeopathic Hormone Rejuvenation, developed by Theresa Dale, ND, CCN, NP.

In "Revitalize Your Hormones: Dr. Dale's 7 Steps to a Happier, Healthier, and Sexier You" (Wiley; May 2005; $15.95/Paper), Dr. Theresa Dale offers a medically proven alternative to invasive and dangerous hormone replacement therapies. With over 20 years of experience as a Naturopathic Doctor, Certified Clinical Nutritionist and researcher, Dr. Dale has helped women balance their hormone levels through safe, non-toxic program. The world's only clinically proven homeopathic hormone rejuvenation formulas used for restoring hormone balance without side effects. These formulas actually produce healthy hormone levels in women of various ages, and eliminate symptoms such as hot flashes, mood swings, low libido, low energy and irregular menses. The formulas are FDA approved and regulated and are prepared at an FDA registered pharmacy. The remedy goes through a lengthy preparation processes. For example, an herb or substance is diluted and prepared in a manner so that just a micro amount of the original substance is left in the final formula. This method of natural preparation enhances all the properties of the herb and amplifies its efficacy. Homeopathic medicine has been used for 200 years throughout the world, and is natural without toxic side effects. See The Wellness Center website for more education about Homeopathy.

The medical establishment's approach to balancing hormones fails to embrace the concept of the body as a natural living system that is capable of self-repair. Its regimens are based on the premise that people need to look outside our bodies for hormone help via one-size-fits-all drugs. The only hormones that are safe for the human body are the ones the body makes. By using a totally natural and homeopathic program, it is possible to restore emotional, physical and sexual health by following simple and safe individualized nutritional and exercise guidelines.

For more information, call Theresa Dale's office at 866 962 6484.

Theresa Dale, ND, CCN, NP

Founder, The Wellness Center For Research & Education, Inc.

Dean, California College of Natural Medicine

www.wellnesscenter.net

###

Contact Information Theresa Dale

The Wellness Center

http://www.wellnesscenter.net

866 962 6484

Dr. Theresa Dale, ND, CCN, NP

The Wellness Center

http://www.wellnesscenter.net

805 984 7200